Topic

New Jersey

A collection of 46 issues

The Complete Guide to Getting Rezlidhia (Olutasidenib) Covered by UnitedHealthcare in New Jersey: Requirements, Appeals, and Step Therapy

Answer Box: Getting Rezlidhia Covered in New Jersey UnitedHealthcare requires prior authorization for Rezlidhia (olutasidenib) in New Jersey, with specific requirements for documented IDH1 mutation and AML diagnosis. The fastest path: (1) Submit PA through the UnitedHealthcare Provider Portal with IDH1 mutation test results, (2) Include medical necessity letter addressing
5 min read

How to Get Poteligeo (mogamulizumab-kpkc) Covered by Humana in New Jersey: Complete Guide with Forms and Appeals

Quick Answer: Getting Poteligeo Covered by Humana in New Jersey Poteligeo (mogamulizumab-kpkc) requires prior authorization from Humana for cutaneous T-cell lymphoma treatment. Submit documentation through CenterWell Specialty Pharmacy showing relapsed/refractory mycosis fungoides or Sézary syndrome with prior systemic therapy failures. If denied, New Jersey's IHCAP external review
6 min read

How to Get Juxtapid (lomitapide) Covered by UnitedHealthcare in New Jersey: Complete Guide with Forms and Appeals

Answer Box: Getting Juxtapid Covered by UnitedHealthcare in New Jersey Juxtapid (lomitapide) requires prior authorization from UnitedHealthcare for homozygous familial hypercholesterolemia (HoFH). First, confirm your diagnosis with genetic testing documentation. Submit the UnitedHealthcare prior authorization form through their provider portal, including proof you've tried other HoFH treatments first.
6 min read